OrganoClick - Right on time (incl. the academic quarter)
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Nyhet

OrganoClick - Right on time (incl. the academic quarter)

No drama in Q4 report Large NWT order has arrived Value range raised to SEK 5-16 (3-13) per share NWT order worth SEK 30m p. a. – better late than never On Friday, 19 February, OrganoClick announced the first high-volume NWT order we have been waiting for, and which was supposed to come during H2’20. OrganoClick is going to deliver its bio-based binders to a leading non-woven producer.

The deal value is estimated to be c. SEK 30m annually once fully implemented, which is expected to happen during 2022. During 2021, the company is going to deliver volumes worth SEK 5.

2m for the period Q2-Q3, with Q4 still unknown. We see this as an important proof-of-concept win that materially lowers the NWT risk. Furthermore, this could boost confidence among the counterparties in the company’s other nine production tests currently in place.

We note that applying the order value on this order to the current production tests would imply sales of SEK 300m, a gross profit of c. 150m and an EBIT of c. SEK 60m from the NWT segment, according to our estimated margins.

No drama in Q4, changes look more severe than reality The company’s Q4 report (announced 17 February) came in line with our expectations with SEK 18m in sales (0% vs. ABGSCe) and EBIT of -9m (-4% vs ABGSCe). On a segment basis, FW came in 11% above our expectations while GCM came in 5% below.

BC again fell short of our expectations. We make estimate cuts of 16-8% to sales, effectively delaying financials by one year. This is partly due to a BC cut (c.

5% group ‘22e impact) due to weaker-than-expected performance, while delaying sales in NWT on longer process timelines. As we now have indications of approximate deal sizes, we pencil one more deal into our ‘22e numbers, with two more deals set to come during ‘23. Keeping in mind that the firm is in nine production tests, our NWT est.

changes do not affect our view of the segment’s value, as they mostly impact 2021e. Value range increased on de-risked NWT segment On.

Artikeln i sin helhet
Denna källa har få eller inga artiklar bakom betalvägg
Läs hela artikeln

Börskollens app – Högt betyg ⭐⭐⭐⭐⭐ och 250.000 nedladdningar

Ladda hem

Vårt nyhetsbrev – Utvalda börsnyheter och heta investeringscase varje vecka

Prenumerera

Nyheter om OrganoClick

Läses av andra just nu

Innehåller annonslänkar

Så kommer du igång med trading

Den här månaden har vi valt att lyfta fram trading som utbildningstema, så att du som läsare ska få en möjlighet att fördjupa dig mer och spetsa dina kunskaper. Nedan finner du ett antal matiga guider och vi lyfter även fram vårt förstahandsval av mäklare och plattform: IG.

STÄNG X
Bästa valet för trading – Bra erbjudande & gratis utbildning
Världsledande global tradingmäklare med prisbelönt app
Gratis att öppna konto & demokonto (fiktiv handel)
KOM IGÅNG

74% av alla icke-professionella kunder förlorar pengar på CFD-handel hos de här leverantörerna.

Populära ekonominyheter

Om aktien OrganoClick

Mer från Introduce

Vinnare & Förlorare

Börskollen använder själva TradingView för analys – prova du med (affiliatelänk)Analysera aktier här

Nyhetsbrev

Senaste nytt